Omri Shor is CEO of Medisafe, a leading digital health company, helping patients manage their treatment journey. Technology has always been an important part of healthcare, and as a result of the digital transformation caused by Covid-19, we've seen rapid advancements that have significantly improved the way care is being delivered. Now, after years of lagging behind other industries, healthcare is finally seeing a rush of new technologies not only being developed but also meaningfully implemented in clinical, administrative and operational applications--and across different types of organizations--to address many of the issues that have long plagued healthcare. The pandemic also led to patients wanting to become more involved in their healthcare decisions. When patients are more engaged in their healthcare journeys, they generally are more satisfied with the care they receive and have better health outcomes.

By Rahul De', Nitisha Ahuja, Palash Sanjay Kotgirwar As Artificial Intelligence (AI) based products and services proliferate across industries one question emerges as the most important: should these systems include a human in the loop or operate autonomously? This question underlies much of the services and products that we take for granted now. Consider, for example, using Google Maps. Many of us now take this AI-based service for granted, when it gives directions to go from one place to another we follow, nearly without thinking about where it is taking us. There is no human guide or moderator behind this tool; we cannot even call a number, like in a bank, and demand to speak to someone about getting wrong directions or being led off somewhere other than our destination.

Last March, Deep Lens partnered with a top global CRO, Worldwide Clinical Trials (WCT), to accelerate confident diagnoses of cancer and streamline oncology trial recruitment, timelines, and workflows. Using Viper, WCT is working to find the most suitable patients for cancer trials at the time of their diagnoses. By working with Deep Lens on clinical trial recruitment, WCT can reach upstream from the oncologist to the pathologist, enabling identification of eligible patients at the time of their diagnosis -- much sooner than current methods. Going straight to the source can fast-track trial enrollment and potentially shorten the duration of the trial.

T1: What impacts do you see #AI & this tech making for healthcare? T1: What impacts do you see #AI & this tech making for healthcare? T2: Are the fears surrounding #AI overblown? What steps and cautions should we consider? T2: Are the fears surrounding #AI overblown?